Open access peer-reviewed chapter

Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Revision

By Manuel Morgado, Sandra Rolo and Miguel Castelo-Branco

Submitted: April 10th 2011Reviewed: November 20th 2011Published: June 29th 2012

DOI: 10.5772/32403

Downloaded: 1844

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Manuel Morgado, Sandra Rolo and Miguel Castelo-Branco (June 29th 2012). Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Revision, Pharmacotherapy, Farid Badria, IntechOpen, DOI: 10.5772/32403. Available from:

chapter statistics

1844total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

LavTIME - A Brand-New Treatment Method of Lasting Wounds - A Multi-Centre Randomized Double-Blind Study on Effectiveness of Polyhexanide and Betaine in Ulcers' Healing with Venous Origin

By Z. Rybak, G Krasowski, R. Wajda and P. Ciesielczyk

Related Book

First chapter

African Plants with Antiproliferative Properties

By Newman Osafo, Yaw Duah Boakye, Christian Agyare, Samuel Obeng, Judith Edem Foli and Prince Amankwaah Baffour Minkah

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us